MAPT and Alzheimer disease: The advent of PET radiotracers that bind to hyperphosphorylated paired helical filaments of aggregated tau has permitted us to characterize the in vivo spatial distribution of tau burden, and how it relates to other pathologic processes in the AD cascade.